Proteolytic truncated pieces of Tau are highly prone to aggregation and contribute to progressive pathology in AD and DS–AD via site-specific phosphorylation, self-aggregation, and binding to hyperphosphorylated and oligomeric Tau [68,69]. The gene discussed is MAPT; the disease is Alzheimer disease.